XML 63 R32.htm IDEA: XBRL DOCUMENT

Related Party Disclosures	12 Months Ended
Related Party Disclosures	Dec. 31, 2019
Related Party Transactions [Abstract]
Related Party Disclosures	Related Party Disclosures On October 1, 2018, the Company entered into the Investment Agreement with the Purchaser relating to the issuance to the Purchaser of $150,000 aggregate principal amount of the Notes. In connection with the investment, Vikram S. Pandit, Chairman and CEO of The Orogen Group LLC (an affiliate of the Purchaser), was appointed to Company’s Board of Directors. The Company had outstanding Notes with a principal amount of $150,000 as of December 31, 2019 and 2018, and interest accrued of $1,313 each as of December 31, 2019 and 2018, related to the Investment Agreement. Refer to Note 18 to the consolidated financial statements for details. The Company provides consulting services to PharmaCord, LLC. One of the Company’s directors, Nitin Sahney, is the member-manager and chief executive officer of PharmaCord, LLC. The Company recognized revenue of $nil, $225 and $1,748 for the years ended December 31, 2019, 2018 and 2017, respectively, for services provided. As of December 31, 2019 and 2018, the Company had accounts receivable of $nil and $5, respectively, related to these services.